Skip to main content

Advertisement

Log in

Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Eighty children with nephrotic syndrome underwent lumbar spine densitometry and vertebral morphometry soon after glucocorticoid initiation. We found an inverse relationship between glucocorticoid exposure and spine areal bone mineral density (BMD) Z-score and a low rate of vertebral deformities (8%).

Introduction

Vertebral fractures are an under-recognized complication of childhood glucocorticoid-treated illnesses. Our goal was to study the relationships among glucocorticoid exposure, lumbar spine areal BMD (LS BMD), and vertebral shape in glucocorticoid-treated children with new-onset nephrotic syndrome.

Methods

Lateral thoracolumbar spine radiography and LS BMD were performed in 80 children with nephrotic syndrome (median age 4.4 years; 46 boys) within the first 37 days of glucocorticoid therapy. Genant semiquantitative grading was used as the primary method for vertebral morphometry; the algorithm-based qualitative (ABQ) method was used for secondary vertebral deformity analysis.

Results

Six of the 78 children with usable radiographs (8%; 95% confidence interval 4 to 16%) manifested a single Genant grade 1 deformity each. All deformities were mild anterior wedging (two at each of T6, T7, and T8). Four of the 78 children (5%; 95% confidence interval 2 to 13%) showed one ABQ sign of fracture each (loss of endplate parallelism; two children at T6 and two at T8). Two of the children with ABQ signs also had a Genant grade 1 deformity in the same vertebral body. None of the children with a Genant or ABQ deformity reported back pain. An inverse relationship was identified between LS BMD Z-score and glucocorticoid exposure.

Conclusions

Although we identified an inverse relationship between steroid exposure and LS BMD soon after glucocorticoid initiation for childhood nephrotic syndrome, there was only a low rate of vertebral deformities. The clinical significance of these findings requires further study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

ABQ:

Algorithm-based qualitative

BMI:

Body Mass Index

BMD:

Bone mineral density

CI:

Confidence interval

GC:

Glucocorticoid

LS:

Lumbar spine

NS:

Nephrotic syndrome

References

  1. Schlesinger ER, Sultz HA, Mosher WE, Feldman JG (1968) The nephrotic syndrome. Its incidence and implications for the community. Am J Dis Child 116:623–632

    PubMed  CAS  Google Scholar 

  2. Hodson EM, Knight JF, Willis NS, Craig JC (2001) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 2

  3. Clark AG, Barratt TM (1999) Steroid-responsive nephrotic syndrome. In: Barratt TM, Avner ED, Harmon WE (eds) Pediatric nephrology, 4th edn. Lippincott, Hagerstown

    Google Scholar 

  4. van Staa TP, Cooper C, Leufkens HG, Bishop N (2003) Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res 18:913–918

    Article  PubMed  Google Scholar 

  5. Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ (2001) Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res 16:97–103

    Article  PubMed  CAS  Google Scholar 

  6. Canalis E, Mazziotti G, Giustina A, Bilezikian JP (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319–1328

    Article  PubMed  CAS  Google Scholar 

  7. Lukert BP (1992) Glucocorticoid-induced osteoporosis. South Med J 85(2):S48–S51

    Google Scholar 

  8. Ruegsegger P, Medici TC, Anliker M (1983) Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 25:615–620

    Article  PubMed  CAS  Google Scholar 

  9. Bak M, Serdaroglu E, Guclu R (2006) Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome. Pediatr Nephrol 21:350–354

    Article  PubMed  Google Scholar 

  10. Acott PD, Wong JA, Lang BA, Crocker JF (2005) Pamidronate treatment of pediatric fracture patients on chronic steroid therapy. Pediatr Nephrol 20:368–373

    Article  PubMed  Google Scholar 

  11. Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA (2004) Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Engl J Med 351:868–875

    Article  PubMed  CAS  Google Scholar 

  12. Sbrocchi AM, Rauch F, Matzinger M, Feber J, Ward LM (2010) Vertebral fractures despite normal spine bone mineral density in a boy with nephrotic syndrome. Pediatr Nephrol 26:139–142

    Article  PubMed  Google Scholar 

  13. Institute of Medicine (1997) Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, fluoride. National Academy Press, Washington

    Google Scholar 

  14. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL (2002) Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45–60

    Article  PubMed  Google Scholar 

  15. World Health Organization Multicentre Growth Reference Study Group (2006) WHO Child Growth Standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. World Health Organization, Geneva, pp 229–300

    Google Scholar 

  16. Marshall WA, Tanner JM (1969) Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291–303

    Article  PubMed  CAS  Google Scholar 

  17. Marshall WA, Tanner JM (1970) Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13–23

    Article  PubMed  CAS  Google Scholar 

  18. Musgrave KO, Giambalvo L, Leclerc HL, Cook RA, Rosen CJ (1989) Validation of a quantitative food frequency questionnaire for rapid assessment of dietary calcium intake. J Am Diet Assoc 89:1484–1488

    PubMed  CAS  Google Scholar 

  19. Halton J, Gaboury I, Grant R et al (2009) Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J Bone Miner Res 24:1326–1334

    Article  PubMed  Google Scholar 

  20. Public Health Agency of Canada. Canada's physical activity guide for children. http://www.phac-aspc.gc.ca/hp-ps/hl-mvs/pag-gap/cy-ej/children-enfants/index-eng.php. Accessed 31 March 2010

  21. van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777–787

    Article  PubMed  Google Scholar 

  22. Curtis JR, Westfall AO, Allison J, Bijlsma JW, Freeman A, George V, Kovac SH, Spettell CM, Saag KG (2006) Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum 55:420–426

    Article  PubMed  Google Scholar 

  23. Dubner SE, Shults J, Baldassano RN, Zemel BS, Thayu M, Burnham JM, Herskovitz RM, Howard KM, Leonard MB (2009) Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease. Gastroenterology 136:123–130

    Article  PubMed  Google Scholar 

  24. Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148

    Article  PubMed  CAS  Google Scholar 

  25. Keats TE, Smith TH (1977) An atlas of normal developmental anatomy. Year book of medical publishers, 2nd Ed. Chicago

  26. Jiang G, Eastell R, Barrington NA, Ferrar L (2004) Comparison of methods for the visual identification of prevalent vertebral fracture in osteoporosis. Osteoporos Int 15:887–896

    Article  PubMed  CAS  Google Scholar 

  27. Newcombe RG (1998) Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17:857–872

    Article  PubMed  CAS  Google Scholar 

  28. Fujita T, Satomura A, Hidaka M, Ohsawa I, Endo M, Ohi H (2000) Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy. Calcif Tissue Int 66:195–199

    Article  PubMed  CAS  Google Scholar 

  29. Cohen A, Shane E (2003) Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int 14:617–630

    Article  PubMed  Google Scholar 

  30. Wetzsteon RJ, Shults J, Zemel BS, Gupta PU, Burnham JM, Herskovitz RM, Howard KM, Leonard MB (2009) Divergent effects of glucocorticoids on cortical and trabecular compartment bone mineral density in childhood nephrotic syndrome. J Bone Miner Res 24(3):503–513

    Article  PubMed  CAS  Google Scholar 

  31. Hegarty J, Mughal MZ, Adams J, Webb NJ (2005) Reduced bone mineral density in adults treated with high-dose corticosteroids for childhood nephrotic syndrome. Kidney Int 68:2304–2309

    Article  PubMed  CAS  Google Scholar 

  32. Dennison E, Cooper C (2000) Epidemiology of osteoporotic fractures. Horm Res 54(Suppl 1):58–63

    PubMed  CAS  Google Scholar 

  33. Valta H, Lahdenne P, Jalanko H, Aalto K, Makitie O (2007) Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis. J Rheumatol 34:831–836

    PubMed  Google Scholar 

  34. Gaca AM, Barnhart HX, Bisset GS 3rd (2010) Evaluation of wedging of lower thoracic and upper lumbar vertebral bodies in the pediatric population. AJR Am J Roentgenol 194:516–520

    Article  PubMed  Google Scholar 

  35. Ebel KD, Blickman H, Willich E, Richter E (1999) Abnormalities in vertebral body shape and size. Differential diagnosis in pediatric radiology. Thieme Publishers, NY

  36. Rea JA, Chen MB, Li J, Blake GM, Steiger P, Genant HK, Fogelman I (2000) Morphometric X-ray absorptiometry and morphometric radiography of the spine: a comparison of prevalent vertebral deformity identification. J Bone Miner Res 15:564–574

    Article  PubMed  CAS  Google Scholar 

  37. Vallarta-Ast N, Krueger D, Wrase C, Agrawal S, Binkley N (2007) An evaluation of densitometric vertebral fracture assessment in men. Osteoporos Int 18:1405–1410

    Article  PubMed  CAS  Google Scholar 

  38. Wu C, van Kuijk C, Li J, Jiang Y, Chan M, Countryman P, Genant HK (2000) Comparison of digitized images with original radiography for semiquantitative assessment of osteoporotic fractures. Osteoporos Int 11:25–30

    Article  PubMed  Google Scholar 

  39. Jackson SA, Tenenhouse A, Robertson L (2000) Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int 11:680–687

    Article  PubMed  CAS  Google Scholar 

  40. Huber A, Gaboury I, Cabral DA et al (2010) Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthitis Care Res (Hoboken) 62:516–526

    Article  CAS  Google Scholar 

  41. Ismail AA, Cooper C, Felsenberg D, Varlow J, Kanis JA, Silman AJ, O'Neill TW (1999) Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. European Vertebral Osteoporosis Study Group. Osteoporos Int 9:206–213

    Article  PubMed  CAS  Google Scholar 

  42. Delmas PD, Genant HK, Crans GG, Stock JL, Wong M, Siris E, Adachi JD (2003) Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone 33:522–532

    Article  PubMed  CAS  Google Scholar 

  43. Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R (1995) Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 54:801–806

    Article  PubMed  CAS  Google Scholar 

  44. Dubner SE, Shults J, Leonard MB, Zemel BS, Sembhi H, Burnham JM (2008) Assessment of spine bone mineral density in juvenile idiopathic arthritis: impact of scan projection. J Clin Densitom 11:302–308

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was primarily funded by an operating grant from the Canadian Institutes for Health Research. Additional funding for this work has been provided by the Canadian Institutes for Health Research New Investigator Program (to Dr. Leanne Ward), the Canadian Child Health Clinician Scientist Career Enhancement Program (to Dr. Leanne Ward), the Children's Hospital of Eastern Ontario, and Women and Children's Health Research Institute, University of Alberta.

In addition, the Canadian STOPP Consortium would like to thank the following individuals who contributed to the study: The children and their families who participated in the study, making the STOPP research program possible; the research associates who managed the study at the coordinating center (the Children's Hospital of Eastern Ontario Ottawa, Ontario): Elizabeth Sykes (STOPP project manager), Maya Scharke (STOPP data analyst and database manager), Monica Tomiak (statistical analyses), Victor Konji (STOPP publications and presentations committee liaison and hand morphometry measurements), Steve Anderson (Children's Hospital of Eastern Ontario, Pediatric Bone Health Program research manager), Catherine Riddell (STOPP national study monitor); and research associates who took care of the patients from the following institutions: Alberta Children's Hospital, Calgary, Alberta—Eileen Pyra; British Columbia Children's Hospital, Vancouver British Columbia—Terry Viczko, Sandy Hwang; Children's Hospital of Eastern Ontario, Ottawa, Ontario—Heather Cosgrove, Amanda George, Josie MacLennan, Catherine Riddell; Children's Hospital of Western Ontario, London, Ontario—Leila MacBean, Mala Ramu; McMaster Children's Hospital, Hamilton, Ontario—Susan Docherty-Skippen; IWK Health Center, Halifax, Nova Scotia—Aleasha Warner; Montréal Children's Hospital, Montréal, Québec—Diane Laforte, Maritza Laprise, Mayito St-Pierre; Ste. Justine Hospital, Montréal, Québec—Claude Belleville, Stéphanie Pellerin, Natacha Gaulin Marion; Stollery Children's Hospital, Edmonton, Alberta—Deborah Olmstead, Melissa Gabruck, Linda Manasterski; Toronto Hospital for Sick Children, Toronto, Ontario—Julie Lee, Karen Whitney; Winnipeg Children's Hospital, Winnipeg, Manitoba—Dan Catte, Erika Bloomfield. The research nurses, support staff, and all the STOPP collaborators from the various Divisions of Nephrology, Oncology, Rheumatology, and Radiology have contributed to the care of the children enrolled in the study.

Funding

The primary funding source is the Canadian Institutes of Health Research. Additional funding sources are from the Canadian Child Health Clinician Scientist Program; the Children's Hospital of Eastern Ontario Research Institute and Departments of Pediatrics and Surgery; and the Women and Children's Health Research Institute, University of Alberta.

Conflicts of Interest

None.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to L. M. Ward.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feber, J., Gaboury, I., Ni, A. et al. Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome. Osteoporos Int 23, 751–760 (2012). https://doi.org/10.1007/s00198-011-1621-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-011-1621-2

Keywords

Navigation